{
  "ptid_time": "123_S_4904_2012-09-06",
  "img_path": "/data/qiuhui/data/adni/images/123_S_4904/2012-09-06/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 45,541 mm³, 103.9% above the reference mean. With a Z-score of 2.60 (99.5th percentile), this represents significant enlargement; hippocampal volume measures 4,823 mm³, 37.2% below the reference mean. With a Z-score of -4.18 (0.0th percentile), this represents profound atrophy; whole brain volume measures 890,781 mm³, 13.4% below the reference mean. With a Z-score of -1.67 (4.7th percentile), this represents moderate atrophy; entorhinal cortex volume measures 2,951 mm³, 24.2% below the reference mean. With a Z-score of -1.87 (3.0th percentile), this represents moderate atrophy; fusiform gyrus volume measures 14,611 mm³, 19.8% below the reference mean. With a Z-score of -2.23 (1.3th percentile), this represents significant atrophy; middle temporal gyrus volume measures 13,668 mm³, 33.4% below the reference mean. With a Z-score of -2.97 (0.2th percentile), this represents significant atrophy. ",
  "text_data": "Age is 65.7 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Neurologic; Cardiovascular; Gastrointestinal; Allergies or Drug Sensitivities; Smoking; Major Surgical Procedures. MMSE: 28.0. MoCA: 28.0. Logical Memory: 1.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.56 SUVR (profound elevated); Amyloid beta: 646.70 pg/mL (normal ); Total tau: 253.40 pg/mL (normal ); Phosphorylated tau: 24.16 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows profound hippocampal atrophy (Z-score -4.18) and significant ventricular enlargement (Z-score 2.60), along with widespread cortical atrophy in key Alzheimer’s-related regions (entorhinal cortex, fusiform gyrus, middle temporal gyrus). Despite normal CSF biomarkers (Aβ, T-tau, P-tau), the AV45 PET scan (profoundly elevated) suggests amyloid pathology. The preserved cognitive scores (MMSE 28, MoCA 28) are discordant with the severe structural changes, possibly indicating preclinical or early-stage disease.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal Alzheimer’s given imaging and AV45, but cognitive scores remain intact).  \n**Confidence:** **Medium** (high confidence in neurodegeneration, but cognitive preservation complicates staging; biomarker discordance—normal CSF Aβ but elevated AV45—warrants caution).  \n\n*Note: If follow-up testing shows cognitive decline, progression to dementia (Alzheimer’s) would be likely. APOE4 homozygosity (2.0) further supports AD risk.*",
  "timestamp": "2025-07-26T12:34:50.092886"
}